REQUEST A DEMO
Total
USD $0.00
Search more companies

Labort Fine-Chem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Labort Fine-Chem Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Labort Fine-Chem Private Limited is an enterprise in India, with the main office in Surat. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on July 31, 2000. 101 - 500 (2025) employees currently work for Labort Fine-Chem Private Limited. The latest financial highlights indicate a net sales revenue increase of 3.12% in 2024. Its total assets grew by 14.58% over the same period. Labort Fine-Chem Private Limited’s net profit margin increased by 0.87% in 2024.

Legal Address
703-704 Icon Business Centre Opp Central Mall
Surat; Gujarat; Postal Code: 395007

Contact Details: Purchase the Labort Fine-Chem Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Labort Fine-Chem Private Limited report to view the information.
Registered Capital:
Purchase the Labort Fine-Chem Private Limited report to view the information.
Financial Auditors:
Purchase the Labort Fine-Chem Private Limited report to view the information.
Incorporation Date:
July 31, 2000
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Labort Fine-Chem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
3.12%
Total Operating Revenue
2.92%
Operating Profit
8.14%
EBITDA
8.05%
Net Profit/Loss for the Period
7.69%
Total Assets
14.58%
Total Equity
26.68%
Operating Profit Margin
1.35%
Net Profit Margin
0.87%
Return on Equity (ROE)
-3.71%
Quick Ratio
1.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?